Dr. Jackson: Patient experience
Dr. Jackson: Therapy in practice
Dr. de Juan: Efficacy and safety
Dr. de Juan: Beta radiation therapy
Dr. Chong: Anti-VEGF therapies
Mr. Bremridge: AMD challenges
Mr. Bremridge: Wet AMD overview
Dr. Pravin Dugel: RPS Presentation
Dr. Pravin Dugel: Clinical Data Review
NeoVista Surgical Procedure
( 
- Click this icon on the player to view in full screen)
Science & Technology
On this page you can view presentations on NeoVista technology, clinical data from past studies, and other topics of interest.
Interviews
Tom Bremridge
Chief Executive, the Macular Disease Society
Interview, July 16, 2008, London.
- What is wet AMD?
- Why is it a significant problem?
- What would a one-time surgical procedure potentially offer?
Eugene de Juan Jr, MD
Jean Kelly Stock Distinguished Professor
University of California, San Francisco
Interview, July 16, 2008, London.
- What is epimacular beta radiation therapy?
- How does epimacular beta radiation therapy differ from other treatments?
- How extensively has the treatment been tested?
- Does the treatment work for all patients?
- What are the risks of epimacular beta radiation?
- What are the risks to healthcare providers?
Tim Jackson, PhD, FRCOphth
King's College Hospital, London
Interview, July 16, 2008, London.
- What has been the experience with epimacular beta radiation in practice?
- How do patients respond to the idea of having surgery compared with other treatments?
- What do patients say about the actual experience?
- Which patients are eligible for beta radiation therapy?
- What is the future of epimacular beta radiation therapy?
- How will beta radiation therapy fit in with other available treatment options?
- Will the treatment be funded by NHS?
Presentations
Tom Bremridge
Chief Executive, the Macular Disease Society
Presentation in London, July 16, 2008.
AMD and the challenges patients face in getting access to treatment.
Eugene de Juan Jr, MD
Jean Kelly Stock Distinguished Professor
University of California, San Francisco
Presentation in London, July 16, 2008.
Selective Epimacular Brachytherapy with anti-VEGF therapy for the treatment of CNV
Tim Jackson, PhD, FRCOphth
King's College Hospital, London
Presentation in London, July 16, 2008.
Epimacular brachytherapy: Early UK experience
Victor Chong, MBChB, FRCS, FRCOphth
Oxford Eye Hospital, University of Oxford
Institute of Ophthalmology, London
University of Aston
Presentation in London, July 16, 2008.
Anti-VEGF therapies: Implications for the future